PATENT CLAIM ANALYSIS

Application Number: 15953523
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
Disclosed are heteroarylcarboxamides of formula (I), and pharmaceutically acceptable salts thereof, wherein A, T, R 1 , R 2  and R 3  are as defined herein. Also disclosed are methods of using these compounds for the treatment of diseases which can be influenced by inhibition of plasma kallikrein.

Claim (Index 12):
The pharmaceutical composition according to  claim 11  wherein the one or more additional therapeutic agents are selected from the group consisting of antidiabetic agents, agents for the treatment of overweight and/or obesity, agents for the treatment of high blood pressure, heart failure and/or atherosclerosis and agents for the treatment of ocular diseases.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.30233
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15770763', '15770762', '14365497', '15764071', '15327706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8117304910999581
- 35 USC 102 Novelty (BERT): 0.5164350123792159
- Combined Prediction Score: 0.7822009432278839
- Mean Citation Score: 278.67441
- Max Citation Score: 335.30173
- Similarity Product: 325.7721046611488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test